23nd Invitation to Manufacturers of Antimalarial Medicines to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit (PQT)

The invitation to Manufacturers of Antimalarial Medicines to submit an Expression of Interest for Product Evaluation to the WHO Prequalification Unit was recently updated. It now includes Artemether/Lumefantrine, dispersible tablet 2.5 mg/30 mg under point 2.